Our vision

"To define is to resolve",
a well and exact definition of your need.

Early and precise definition of your scientific needs is essential to the identification and validation of your candidate cancer therapeutics.

Our Business Development team, in close coordination with our scientific staff, is available to assist you in the identification and conception of the most appropriate solutions to your preclinical drug development needs, in order to position your molecules along the most efficient development pathway.

"Interconnected departments and skills",
your project is at the heart of the connection.

Put into practice, our concept of "Connection", fortified by experience acquired through the performance of hundreds of studies over the past 12 years, allows you to benefit from our unrivaled technological platform, our network of excellence and our rigorous and tested methodology.
Above all, our efficacy lies in an internal organization focused on the transversal link between knowledge, expertise, the exchange of information, and the synergy of various skill sets.

It is the diversity and complementarity of our "human capital" :
Researchers, pharmacologists, pharmacists, technicians, administrative staff and advisors all united by the same respect of core values, which constitutes Oncodesign's greatest wealth. We share this wealth with you and our partners through close collaboration and research programs of high added value.

"A qualifying approach ",
from the reduction of scientific risk to the reduction of financial risk.

Oncodesign has focused on a "Qualifying" concept aiming to explore a reduced number of molecules.
This approach optimizes the therapeutic potential of specific molecules, allowing us to identify and select the most effective anticancer drugs in a flexible, rapid, reliable and efficient manner.

This reduction of scientific risk results in the eventual reduction of financial risk.